American Society of Hematology/LinkedIn
Sep 22, 2026, 07:39
Better Trials and Better Treatments Through Greater Inclusion – American Society of Hematology
American Society of Hematology shared a post on LinkedIn about a recent article by Alan Mast and Leonard A Valentino, published in JAMA Oncology, adding:
“Better representation can lead to better trials and better treatments.
Alan Mast, MD, PhD, and Leonard A. Valentino, MD, discuss why inclusion in clinical research matters, steps ASH is taking to address barriers to participation, and tools available to help build more representative clinical trials.”
Title: Better Trials, Better Treatments: Advancing Inclusion and Representation in Clinical Trials
Authors: Alan Mast and Leonard A. Valentino
Other posts featuring American Society of Hematology on Hemostasis Today.
Alan Mast
American Society of Hematology
ASH
Clinical Research
clinical research participation
clinical trials
diversity in clinical trials
health equity
Hematologic Malignancies
Hematology
Hemostasis News
Hemostasis Today
JAMA Oncology
Leonard A. Valentino
Medical Research
Oncology
patient inclusion
representation in research
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause